Updates to the Handbook

Removed all information related to NeisVac-C as it is no longer available.

Re-added Avaxim, reverting the previous change which removed it. This error occurred due to conflicting information regarding supply availability.

Re-added Avaxim, partially reverting elements of the previous change which removed it. This error occurred due to conflicting information regarding supply availability.

Updated to include ibuprofen for pain relief. 

Addition of ibuprofen to the section on managing pain and fever after vaccination.

Addition of epidemiological evidence on rates of GBS after RSV vaccination.

Updated hyperlink for Northern Territory AEFI form.

Updated pneumococcal catch-up table headings to improve clarity of who is included.

Updated the MMR/MMRV in minimum age catch-up table so that MMRV as a first dose can only be given after 4 years of age.

Updated to include details of how vaccine minimum intervals are described in the handbook and how a month is calculated for this purpose.

HepB, Hib and pneumococcal vaccine minimum intervals updated to align with language used for other vaccines for consistency across Handbook.

Removal of text describing booster doses for Hib as it was unclear and inconsistent with Hib catch up table.

Removed Avaxim as it is no longer available.

Hepatitis B vaccine minimum intervals updated to align with language used for other vaccines for consistency across Handbook.

HPV vaccine minimum intervals updated to align with language used for other vaccines for consistency across Handbook.

Japanese Encephalitis vaccine minimum intervals updated to align with language used for other vaccines for consistency across Handbook.

Updated to include ibuprofen for pain relief.

Removed endemic areas to broaden regions of travel for early MMR dose advice for infants.

Updated to specify that infant travellers who receive an early dose of MMR at ≥ 11 months of age but before 12 months may not need a repeat dose, aligning with existing guidance on minimum acceptable age for first dose of MMR.

Expansion of groups recommended primary vaccination to include humanitarian workers and travellers to a clade I mpox region who might undertake sexual risk activities. Update to post-exposure prophylaxis vaccination to recommend vaccination for both high and medium risk contacts. Restructuring of booster dose guidance following first- and second-generation vaccines to improve clarity.

Updated to include ibuprofen for pain relief.

Removed endemic areas to broaden regions of travel for early MMR dose advice for infants.

Updated to specify that infant travellers who receive an early dose of MMR at ≥ 11 months of age but before 12 months may not need a repeat dose, aligning with existing guidance on minimum acceptable age for first dose of MMR.

Pneumococcal vaccine minimum intervals updated to align with language used for other vaccines for consistency across Handbook.

Updated pneumococcal catch-up table headings to improve clarity of who is included. As well as additional text added to align with pneumococcal chapter to explain there is a lifetime limit of 2 doses of 23vPPV.

Updated to clarify that in transitional scenarios, once a child receives a dose of 20vPCV instead of 23vPPV, then no further doses are required.

Updated to clarify the 20vPCV dose recommended for children aged ≥12 months to 18 years with risk conditions is additional to the recommended routine schedule for non-Indigenous children.

Pneumococcal vaccine minimum intervals updated to align with language used for other vaccines for consistency across Handbook.

Updated to include details of how vaccine minimum intervals are described in the handbook and how a month is calculated for this purpose.

Removed Avaxim and NeisVac-C from the list of vaccine components as they are no longer available.

Addition of guidance for vaccination of individuals with a history of GBS unrelated to previous vaccination and individuals with a history of GBS following previous vaccination.

Addition of epidemiological evidence on rates of GBS after RSV vaccination.

Updated to include ibuprofen for pain relief.

Removed endemic areas to broaden regions of travel for early MMR dose advice for infants.

Updated to specify that infant travellers who receive an early dose of MMR at ≥ 11 months of age but before 12 months may not need a repeat dose, aligning with existing guidance on minimum acceptable age for first dose of MMR.

Pneumococcal, hepatitis B and HPV vaccine minimum intervals updated to align with language used for other vaccines for consistency across Handbook.

Updated pneumococcal catch-up table headings to improve clarity of who is included.

Pneumococcal vaccine minimum intervals updated to align with language used for other vaccines for consistency across Handbook.

Updated pneumococcal catch-up table headings to improve clarity of who is included.